share_log

Stephens & Co. Upgrades CareDx to Overweight, Announces $10 Price Target

Stephens & Co. Upgrades CareDx to Overweight, Announces $10 Price Target

Stephens & Co.將CaredX上調至增持,宣佈10美元的目標股價
Benzinga ·  2023/11/09 09:20

Stephens & Co. analyst Mason Carrico upgrades CareDx (NASDAQ:CDNA) from Equal-Weight to Overweight and announces $10 price target.

斯蒂芬斯公司分析師梅森·卡里科將CareDx(納斯達克股票代碼:CDNA)從等權重上調至增持,並宣佈了10美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論